Priority Date: 16.12.11 (EP 20110306686)

TREATMENT OF CANCER BY INHIBITION OF THE MYD88/ERK MAP KINASE INTERACTION

  • Application ID: EP12808362
  • Status: PATENT GRANTED

Attorney

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 16.12.2011 - Priority Date (EP 20110306686)
  • 20.06.2013 - Publication A1 (WO2013087937)
  • 22.10.2014 - Publication A1 (EP2791674)
  • 06.07.2016 - Publication B1 (EP2791674)

IPC Classification